Results 71 to 80 of about 14,319 (252)

Bilateral ischemic optic neuropathy after transurethral prostatic resection: a case report

BMC Ophthalmology, 2006
Background Nonarteritic ischemic optic neuropathy affects the anterior portion of the optic nerve and is characterized by sudden, painless visual loss. The affected eye has a relative afferent pupillary defect. The typical funduscopic appearance includes
Maldonado Miguel J, Garcia-Layana Alfredo, Sadaba Luis M, Berian Jose M   +3 more
doaj   +1 more source

A case of nonarteritic anterior ischemic optic neuropathy of a male with family history of the disease after receiving sildenafil [PDF]

, 2011
T Felekis1, I Asproudis1, K Katsanos2, EV Tsianos21University Eye Clinic of Ioannina, Ioannina, Greece; 2First Department of Internal Medicine, University Hospital of Ioannina, Ioannina, GreeceAbstract: A 51-year-old male was referred to the University ...
Tsianos EV, Felekis T, Asproudis I, Katsanos K   +3 more
core  

Clinical Outcomes of Photobiomodulation Therapy for Inferior Alveolar Nerve Injury: A Retrospective Analysis

Lasers in Surgery and Medicine, EarlyView.
ABSTRACT Objectives This retrospective study evaluated the clinical outcomes associated with a photobiomodulation therapy (PBMT) protocol in patients with inferior alveolar nerve (IAN) injury following oral and maxillofacial surgery. The study specifically investigated whether the etiology of paresthesia, the time elapsed before treatment initiation ...
Halenur Ates, Yavuz Tolga Korkmaz
wiley   +1 more source

Correction of ischemic optic neuropathy in rats by carbamylated darbepoetin [PDF]

Research Results in Pharmacology, 2018
Introduction: The protective effects of carbamylated darbepoetin on the model of ischemic optic neuropathy in rats were revealed. Objectives: To increase the effectiveness of pharmacological correction of experimental ischemic optic neuropathy in
Anna A. Peresypkina
doaj   +3 more sources

Tacrolimus associated Ischemic Optic Neuropathy [PDF]

, 2017
Tacrolimus is widely used immunosuppressant and though neurotoxicity is well recognized as a side effect, the risk of toxic optic neuropathy is low and described in a few case reports.
Shuai-Chun Lin; Hang Pham; Sangeeta Khanna
core  

Phenotypic Exploration in Patients with Heterozygous Variant in AFG3L2 Gene: A Case‐Series and Literature Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Variants in AFG3‐Like Matrix AAA Peptidase, Subunit 2 (AFG3L2) gene are associated with diverse clinical phenotypes. Here, we describe phenotypic findings of two unrelated children with de novo heterozygous variant and one family with inherited heterozygous variant in AFG3L2 gene.
Sangeetha Yoganathan, Laura Tochen, Jacky Ganguly, Sayoni Roy Chowdhury, Haya S AlFaris, Vivek Pai, Andrea LeBlanc‐Millar, Sara Breitbart, Hrishikesh Kumar, Manohar Shroff, Arun Reginald, Grace Yoon, Alfonso Fasano, George M Ibrahim, Carolina Gorodetsky   +14 more
wiley   +1 more source

Sphenoethmoid mucocele: a rare cause of optic neuropathy [PDF]

Journal of Research in Clinical Medicine
Introduction: The causes of optic neuropathy include ischemic optic neuropathy, infectious agents, inflammatory processes, and compressive lesions. Although a paranasal sinus mucocele is a rare cause of compressive optic neuropathy, it can be treatable ...
Witoon Mitarnun, Korrapat Aegakkatajit, Nutdanai Roila, Nithinan Uepechpong   +3 more
doaj   +1 more source

Presumed clomiphene-induced optic neuropathy: A case report

International Journal of Reproductive BioMedicine, 2021
Background: Clomiphene citrate is an estrogen receptor ligand with mixed agonistic–antagonistic properties used for the treatment of female and male infertility.
Yousef Alizadeh, Zahra Moravvej, Yaser Khakpour, Ebrahim Azaripour, Mitra Akbari, Reza Soltani-Moghadam   +5 more
doaj   +1 more source

Visual Fields in the Ischemic Optic Neuropathy Treatment Trial at Baseline and Follow-up [PDF]

, 2005
A computerized system was developed to analyze Humphrey visual fields obtained from patients with non- arteritic anterior ischemic optic neuropathy (NAION) and enrolled in the Ischemic Optic Neuropathy Decompression Trial (IONDT)
Steven E. Feldon, MD; Lori Levin, MS; Roberta W. Scherer, PhD; Anthony Arnold, MD; Sophia M. Chung, MD; Lenworth Johnson, MD; Gregory Kosmorsky, DO; Steven A. Newman, MD; Joanne Katz, PhD; Patricia Langenberg, PhD; P. David Wilson, PhD; Shalom E. Kelman, MD; Kay Dickersin, PhD (for the Ischemic Optic Neuropathy Decompression Trial Group)
core  

Data‐Driven Insights into Hyperkinetic Disorders in Neurodevelopmental Syndromes and Epileptic Encephalopathies

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Childhood‐onset hyperkinetic movement disorders occur in a range of genetic conditions. Recently, there has been an increase in recognition of hyperkinetic movement disorders, mainly dystonia, chorea and dyskinesia, with monogenic conditions associated with neurodevelopmental delay (NDD) and also with developmental and epileptic ...
Hugo Morales‐Briceño, Shekeeb S. Mohammad, Rajeshwar Reddy Angiti, Velda Han, Michel Tchan, Russell C. Dale, Victor S.C. Fung   +6 more
wiley   +1 more source